Vertaling van "transfusion-related acute lung " (Frans → Nederlands) :

Abréviations utilisées: ADN = acide désoxyribonucléique; ALI = acute lung injury ; BNP = peptide natriurétique de type B; HLA = human leukocyte antigen ; HNA = human neurophil antigen; NTproBNP = pro-peptide N-terminal du BNP; SHOT = Serious Hazards Of Transfusion; TACO = transfusion associated circulatory overload; TRALI = transfusion-related acute lung injury.
Gebruikte afkortingen: DNA = desoxyribonucleic acid; ALI = acute lung injury; BNP = brain natriuretic peptide van type B; HLA = human leukocyte antigen; HNA = human neurophil antigen; NT-proBNP = N-terminaal pro-peptide van BNP; SHOT = Serious Hazards Of Transfusion; TACO = transfusion associated circulatory overload; TRALI = transfusion-related acute lung injury.

Abréviations utilisées: ARDS = acute respiratory distress syndrome; ALI = acute lung injury; CMV = cytomégalovirus; CTCAE = common terminology criteria for adverse events; DNA = desoxyribonucleic acid; CCI = corrected count increment; PRT = pathogen reduction technology; RNA = ribonucleic acid; TRALI = transfusion related acute lung injury; UVA = ultraviolet A light; UVB = ultraviolet B light; UVC = ultraviolet C light.
Gebruikte afkortingen: ARDS = acute respiratory distress syndrome; ALI = acute lung injury; CMV = cytomegalovirus; CTCAE = common terminology criteria for adverse events; DNA = desoxyribonucleic acid; CCI = corrected count increment; PRT = pathogen reduction technology; RNA = ribonucleic acid; TRALI = transfusion related acute lung injury; UVA = ultraviolet A light; UVB = ultraviolet B light; UVC = ultraviolet C light.

Abréviations utilisées: 2-3-DPG = 2,3-diphosphoglycérate; ACTH = adrénocorticotrophine; AGE = advanced glycation end products; ATP = adénosine triphosphate; CE = concentré érythrocytaire; CEC = circulation extra-corporelle; CPD(A) = citrate phosphate dextrose (adénine); GPIIb/IIIa = glycoprotéine IIb/IIIa; GvHD = graft versus host disease; H 2 O 2 = peroxyde d’hydrogène; ICAM = inter-cellular adhesion molecule; ICU = intensive care unit; IgG = immunoglobuline G; IL = interleukine; LDH = lactate déshydrogénase; MODS = multiple organ dysfunction syndrome, syndrome de défaillance polyviscérale; NO = oxyde nitrique; NTBI = nontransferrin-bound iron; PICU = pediatric intensive care unit; PgE 2 = prostaglandine E 2 ; pO 2 = pression partielle d’oxygène; PS = phosphatidylsérine; RAGE = récepteur d’advanced glycation end products; RCT = randomised controled trial, étude randomisée contrôlée; ROS = reactive oxygen species; SIRS = systemic inflammatory response syndrome, syndrome de réponse inflammatoire systémique; SNO = nitrosothiol; TNF = tumour necrosis factor, facteur de nécrose tumorale; TRALI = transfusion related acute lung injury; VCAM = vascular cell adhesion molecule; VO 2 = consommation d’oxygène.
Gebruikte afkortingen: 2-3-DPG = 2,3-diphosphoglyceraat; ACTH = adrenocorticotrofin; AGE = advanced glycation end products; ATP = adenosine trifosfaat; CPD(A) = citraat fosfaat dextrose (adenine); EC = erytrocytenconcentraat; ECC = extracorporele circulatie; GvHD = graft versus host disease; H 2 O 2 = waterstofperoxyd; ICAM = inter-cellular adhesion molecule; ICU = intensive care unit; IgG = immunoglobuline G; IL = interleukine; LDH = laktaat dehydrogenase; MODS = multiple organ dysfunction syndrome, multi-orgaanfalen; NO = oxyde nitrique; NTBI = nontransferrin-bound iron; PICU = pediatric intesnsive care unit; PgE 2 = prostaglandine E 2 ; pO 2 = partielle zuurstofdruk; PS = fosfatidylserine; RAGE = advanced glycation end products receptor; RCT = randomised controled trial, gerandomiseerde gecontroleerde studie; ROS = reactive oxygen species; SIRS = systemic inflammatory response syndrome, systemisch inflammatoir responssyndroom; SNO = nitrosothiol; TNF = tumor necrosis factor; TRALI = transfusion related acute lung injury; VCAM = vascular cell adhesion molecule; VO 2 = zuurstofverbruik.

Les lysophospholipides libérés pourraient aggraver une pathologie pulmonaire existante chez le receveur et intervenir dans la pathogénie du TRALI - transfusion related acute lung injury (Silliman et al., 1997; Silliman
De vrijgekomen lysofosfolipiden zouden een bestaande longpathologie bij de ontvanger kunnen verergeren en misschien een rol spelen in de pathogenese van TRALI (Silliman et al., 1997; Silliman et al., 2011).

La lésion pulmonaire aiguë post-transfusionnelle (transfusion-related acute lung injury – TRALI) est une affection dont l’évolution peut être grave et qui apparaît durant ou peu après l’administration de composants sanguins (Kleinman et al., 2004; Goldman et al., 2005; Saidenberg et al., 2010).
Het transfusiegerelateerd acuut longletsel (transfusion-related acute lung injury – TRALI) is een aandoening met een mogelijks ernstig verloop die ontstaat tijdens of kort na de toediening van bloedcomponenten (Kleinman et al., 2004; Goldman et al., 2005; Saidenberg et al., 2010).

Cet article scientifique, «Recommendations in the event of a suspected transfusion-related acute lung injury (TRALI)», a été diffusé largement.
Het wetenschappelijk artikel " Recommendations in the event of a suspected transfusion-related acute lung injury (TRALI)" werd wijd verspreid.

La forme classique (transfusion-related acute lung injury ou TRALI) est liée au transfert passif
De klassieke vorm (transfusion-related acute lung injury of TRALI) wordt veroorzaakt door